Aspect Biosystems is a biotechnology company pioneering the development of bioprinted tissue therapeutics to transform the treatment of currently incurable diseases. Aspect is creating these next generation cell therapies by applying its full-stack tissue therapeutic platform, which combines the company’s proprietary bioprinting technology, therapeutic cells, biomaterials, and computational design. Aspect’s bioprinted tissue therapeutics are designed to replace, repair, or supplement biological function inside the body with the aim of treating currently incurable diseases such as type 1 diabetes as well as genetic and acquired liver diseases.
Biotechnology Research, Surgical equipment and instruments, Health, medical and pharmaceutical, Chemicals, Pharmaceuticals & Plastics, Medical and surgical equipment, veterinary, Medical equipment and instruments, Laboratory equipment, specialised, Chemical industry plant and equipment, Testing equipment for industries (NES), Measuring and testing equipment